Detection of high‑risk human papillomavirus DNA in sentinel lymph nodes of patients with cervical cancer
- Yan Lu
- Xun Xu
- Xiu‑Hong Nong
- De‑Sheng Yao
Affiliations: Department of Gynecological Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530000, P.R. China
- Published online on: January 23, 2020 https://doi.org/10.3892/ol.2020.11337
Copyright: © Lu
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
The aim of the present study was to investigate the expression of human papillomavirus (HPV) DNA in sentinel lymph nodes (SLN) in patients with early‑stage cervical cancer (CC). In addition, the present study compared the positive rate of SLNs metastasis detected by routine pathological examination, and investigated the value of HPV‑DNA in the detection of early CC lymph node micrometastasis. Reverse transcription‑quantitative PCR (RT‑qPCR) was used in order to evaluate the HPV DNA detection in all CC samples [International Federation of Gynecology and Obstetrics (FIGO) stage IA2‑IIA2]. The consistency of HPV‑DNA was compared between primary lesions and SLNs. The positive rates of HPV‑DNA were compared with pathological diagnosis of SLN metastasis, and the association between the positive expression of HPV‑DNA in SLNs and the clinical and pathological parameters of patients with cervical cancer were analyzed. A total of 345 sentinel lymph nodes were detected in 100 patients with IA2‑IIA2 CC. The positive rates of RT‑qPCR and conventional histopathological detection of SLNs metastasis were 31.6% (109/345) and 12.8% (44/345), respectively (P<0.001). The positive expression of HPV‑DNA in SLNs was associated with the clinical stage and tumor diameter (P<0.05), but not with patients' age, depth of cervical invasion, histological grade, lymphatic and vascular space invasion (LVSI), squamous cell carcinoma antigen (SCCAg) (P>0.05). The detection of HPV‑DNA expression in pelvic lymph nodes of early CC may be used to improve the detection rate of micrometastasis, guide the postoperative adjuvant therapy more accurately and improve prognosis. Patients with positive HPV‑DNA would require closer surveillance than those with negative HPV‑DNA.